7.84
-0.34(-4.16%)
Currency In USD
| Previous Close | 8.18 |
| Open | 8.28 |
| Day High | 8.28 |
| Day Low | 7.8 |
| 52-Week High | 3,500.42 |
| 52-Week Low | 6.2 |
| Volume | 26,421 |
| Average Volume | 134,134 |
| Market Cap | 4.57M |
| PE | -0.65 |
| EPS | -12.12 |
| Moving Average 50 Days | 7.73 |
| Moving Average 200 Days | 92.24 |
| Change | -0.34 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.02 as of October 22, 2025 at a share price of $7.84. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 2 years ago, it would be worth $0.15 as of October 22, 2025 at a share price of $7.84.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
GlobeNewswire Inc.
Oct 14, 2025 10:09 AM GMT
Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility for continued commercial growth Nociscan scan volumes increase +89% year-over-year with third consecutive quarter of recor
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
GlobeNewswire Inc.
Oct 13, 2025 10:00 AM GMT
Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that disc chemistry is the critical biomarker for diagnosi
Aclarion to Present at the LD Micro Main Event XIX
Newsfile
Oct 09, 2025 10:00 AM GMT
Presentation on Monday, October 20, 2025 at 12:00 PM PTBroomfield, Colorado--(Newsfile Corp. - October 9, 2025) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarke